Philip Nickson
Consejero General en MONTE ROSA THERAPEUTICS, INC. .
Fortuna: - $ al 31/05/2024
Cargos activos de Philip Nickson
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Consejero General | 01/03/2021 | - |
Historial de carrera de Philip Nickson
Antiguos cargos conocidos de Philip Nickson.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/01/2012 | 01/03/2021 |
Formación de Philip Nickson.
| Suffolk University | Graduate Degree |
| The University of Manchester | Doctorate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Reino Unido | 2 |
Operativa
| General Counsel | 1 |
| Corporate Officer/Principal | 1 |
| Graduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Momenta Pharmaceuticals, Inc.
 Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Philip Nickson
- Experiencia
